Immunization against experimental murine salmonellosis with liposome-associated O-antigen.
AUTOR(ES)
Desiderio, J V
RESUMO
Partially delipidated Salmonella typhimurium (O-1,4,5,12) lipopolysaccharide was incorporated into small multilamellar liposomes composed of either naturally occurring or synthetic phospholipids. Vaccination of mice with the liposome-lipopolysaccharide complexes induced a cellular response specific for O-1,4,5,12 determinants, as determined by the development of a delayed-type hypersensitivity reaction. The liposome-lipopolysaccharide vaccines were significantly more effective, compared with other nonviable vaccines tested, in protecting mice against a lethal intravenous challenge infection with virulent S. typhimurium. Protection afforded by the liposome-lipopolysaccharide vaccines was comparable to that conferred by a live S. typhimurium vaccine. Results suggest that liposome-induced modulation of the host immune response in favor of cell-mediated immunity may be more efficacious in preventing diseases in which cell-mediated immunity is of prime importance.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=261222Documentos Relacionados
- Adjuvant Activity of Monophosphoryl Lipid A for Nasal and Oral Immunization with Soluble or Liposome-Associated Antigen
- Preparation and properties of liposome-associated gentamicin.
- Altered pharmacological properties of liposome-associated human interferon-alpha.
- Interactions of lipid a and liposome-associated lipid A with Limulus polyphemus amoebocytes.
- Analysis of the Coliphage T5 DNA Ejection Process with Free and Liposome-Associated TonA Protein
